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ABSTRACT
Our study focuses on a family of ubiquitously ex-
pressed human C2H2 zinc finger proteins comprised
of ZFX, ZFY and ZNF711. Although their protein
structure suggests that ZFX, ZFY and ZNF711 are
transcriptional regulators, the mechanisms by which
they influence transcription have not yet been eluci-
dated. We used CRISPR-mediated deletion to create
bi-allelic knockouts of ZFX and/or ZNF711 in female
HEK293T cells (which naturally lack ZFY). We found
that loss of either ZFX or ZNF711 reduced cell growth
and that the double knockout cells have major de-
fects in proliferation. RNA-seq analysis revealed that
thousands of genes showed altered expression in
the double knockout clones, suggesting that these
TFs are critical regulators of the transcriptome. To
gain insight into how these TFs regulate transcrip-
tion, we created mutant ZFX proteins and analyzed
them for DNA binding and transactivation capability.
We found that zinc fingers 11–13 are necessary and
sufficient for DNA binding and, in combination with
the N terminal region, constitute a functional trans-
activator. Our functional analyses of the ZFX family
provides important new insights into transcriptional
regulation in human cells by members of the large,
but under-studied family of C2H2 zinc finger proteins.
INTRODUCTION
RNA Polymerase 2 (Pol2)-mediated gene regulation is
achieved, in part, by transcription factors (TFs) binding
to a core promoter, defined as a region ±50 bp from the
transcription start site (TSS) of a gene (1–4). Core promot-
ers are composed of common sequence elements such as a
TATA box or a CpG island (which is a genomic region with
high GC content and a high density of CpG dinucleotides).
TATA box-containing promoters often produce cell type-
specific or induced (e.g. by a hormone) transcripts, whereas
housekeeping genes are often driven byCpG island promot-
ers (5). Both types of core promoters are bound by general
TFs such as Pol2 and other components of the pre-initiation
complex. However, a core promoter alone does not provide
robust transcription, due to unstable interactions of the gen-
eral transcriptional machinery with theDNA. Promoter ac-
tivity can be increased by the action of site-specific, DNA-
binding TFs that either bind proximal to the core promoter,
stabilizing the recruitment of the transcriptional machin-
ery, or to distal enhancer elements, bringing specific co-
regulators to the core promoter via long-range chromatin
looping (6).
There are ∼1600 TFs that have sequence-specific DNA
binding properties (7,8). Alterations in gene expression
caused by the inappropriate level, structure, or function of a
site-specific, DNA-binding TF have been associated with a
diverse set of human diseases, including cancers and devel-
opmental disorders (7,9,10), indicating the importance of
understanding the normal and abnormal functions of these
regulatory proteins. Site-specific DNA-binding TFs are
classified according to their DNA binding domains, which
provide useful information concerning their DNA binding
patterns and their evolutionary relatedness (7). C2H2 zinc
fingers (ZFs) comprise the largest class of site-specific DNA
binding proteins encoded in the human genome (11); of the
∼1600 predicted human DNA binding transcription fac-
tors, 747 contain C2H2 zinc finger domains (8). This abun-
dance suggests that the C2H2 zinc finger proteins (ZNFs)
may be critical regulators of a large number of important bi-
ological networks. However, the majority of these TFs have
not been well-studied, due to issues related to low expres-
sion levels, poor antibody quality, and a lack of knowledge
as to what tissue or physiological processes they may regu-
late.
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Figure 1. The ZFX gene family. Shown are gene structure schematics for
ZFX, ZFY and ZNF711. Dashed lines indicate zinc fingers conserved be-
tween ZFX and the other two family members. NLS: nuclear localization
sequence.
Our studies have focused on a small family of human
C2H2 ZNFs that are ubiquitously expressed in human tis-
sues. A Treefam (http://www.treefam.org) analysis reveals
thatmembers of the family include ZFX, ZFYandZNF711
(Supplementary Figure S1A). ZFX and ZFY are nearly
identical proteins encoded on either the X or Y chromo-
some, respectively (having 96% overall similarity, with 99%
similarity in the zinc finger domains). ZNF711 is highly re-
lated to the other two family members, having 67% overall
similarity with ZFX and 87% similarity in the zinc finger
domains (Figure 1). Although previous studies have recog-
nized the high similarity of ZFX and ZFY (12), the rela-
tionship of ZNF711 to ZFX and ZFY has only been re-
cently noted (13). The next closest human ZNF identified
by the Treefam analysis is ZNF639. However, we have not
included ZNF639 in the ZFX family because it has only a
25% similarity to ZFX. ZFX and ZFY have 13 zinc finger
domains at the C-terminal end of the protein; ZNF711 has
amino acid differences that disrupt ZF3 and ZF7 and thus
has only 11 ZFs. All 3 proteins have an acidic domain at
the N-terminus and a nuclear localization signal between
the acidic domain and the zinc finger domains; see Supple-
mentary Figure S1B for a comparison of the amino acid
sequences of the ZFX family members.
Of the three family members, ZFX has been the most
studied in relation to a variety of human cancers. In fact,
it has been implicated in the initiation or progression of
many different types of human cancers, including prostate
cancer, breast cancer, colorectal cancer, glioma, renal car-
cinoma, gastric cancer, gallbladder adenocarcinoma, non-
small cell lung carcinoma and laryngeal squamous cell car-
cinoma (14–23). In these previous studies, it was shown
that high expression of ZFX correlates with poor survival
of cancer patients. Based on its increased levels and asso-
ciation with poor survival in many different cancer types,
ZFX does not appear to be a tumor type-specific onco-
gene, but rather increased levels of ZFX (and perhaps also
ZFY and ZNF711) may generally contribute to metaplas-
tic transformation via causing tumor-promoting changes
in the transcriptome. However, the mechanism(s) by which
the ZFX family influences transcriptional regulation has
not been determined. Therefore, we created knockout cells
lacking expression of all ZFX family members, identified
genes responsive to loss of these TFs, characterized and
compared the binding patterns of ZFX, ZFY, and ZNF711
using ChIP-seq and ChIP-exo, and performed structure–
functional analyses of the ZFX protein, identifying regions
sufficient for DNA binding and transactivation.
MATERIALS AND METHODS
Overall design study
We created single and double knockout clones lacking ZFX
and ZNF711 from female HEK293T cells (which naturally
lack ZFY) and performed RNA-seq to examine effects on
the transcriptome. We also performed ChIP-seq (extend-
ing our studies to include a male cell line to allow anal-
ysis of all three family members) and ChIP-exo to iden-
tify direct target genes of these TFs. We classified the ZFX
family member binding sites using all known TSS from
GENCODE release 19 (GRCH37.p19) and known CpG is-
lands from UCSC table browser (http://genome.ucsc.edu/
cgi-bin/hgTables). Finally, we created a series of FLAG-
tagged ZFX mutant proteins and assayed the mutant pro-
teins for DNA binding and transcriptional activity. A list
of all genomic datasets used in this study can be found in
Supplementary Table S1.
Cell culture
Human kidney HEK293T (ATCC #CRL-3216) and
prostate cancer 22Rv-1 (ATCC #CCL-2505) cells were
obtained from ATCC (https://www.atcc.org/). Cells were
cultured in appropriate media (HEK293T in DMEM and
22Rv1 in RPMI 1640) supplemented with 10% fetal bovine
serum (Gibco by Thermo Fisher #10437036) plus 1%
penicillin and 1% streptomycin at 37◦C with 5% CO2. Cell
lines were authenticated via the STR method and validated
to be mycoplasma free using a universal mycoplasma
detection kit (ATCC #30-1012K).
CRISPR/Cas9-mediated genomic deletions
Guide RNAs used to create ZFX and ZNF711 functional
deletions (see Supplementary Table S2) were cloned into
pSpCas9(BB)-2A-Puro (PX459) V2.0 plasmid (Addgene
#62988). HEK293T cells were transfected with PX459 V2.0
expressing Cas9 plus the gRNAs or with the PX459 V2.0
vector only (which expressed Cas9 but not guide RNAs)
using Lipofectamine 3000 (Thermo Fisher #L3000015),
according to the manufacturer’s protocol. Twenty four
hours after transfection, cells were selected with 2 ng/ul
puromycin for 24 h and then harvested. Post-selection cell
pools are stained with DAPI (Thermo Fisher #62248)
and sorted for live cells using BD FACSAria Ilu SORP
(USC Flow Cytometry Facility). Live single cells were
sorted individually into a well of 96-well plates contain-
ing growth media for HEK293T (described above). Ge-
nomic DNA of single cell-derived clonal populations was
extracted using QuickExtract DNA Extraction Solution
(Epicentre #QE9050), following the manufacturer’s pro-
tocol and was used in PCR-based homozygous deletion
screening assays with primers listed in Supplementary Ta-
ble S2. We identified multiple colonies that showed com-
plete deletion of the DNA between the paired guide RNAs
(not shown). RNA from those single cell-derived clonal
populations was harvested using DirectZol RNAMiniPrep
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kit (Zymo #R2052) according to the manufacturer’s pro-
tocol. cDNA was synthesized using the SuperScript VILO
cDNA Synthesis Kit (Life Technologies #11754-050) fol-
lowing the manufacturer’s protocol and used in qPCR-
based (Quantabio #95054-02K) assays with primers listed
in Supplementary Table S2. These assays demonstrated that
there was no detectable RNA corresponding to the region
within the deleted coding regions (not shown). Finally, a
western blot was performed to demonstrate that there was
no expression of ZFX or ZNF711 protein in the clones (see
Figure 2C).
Cell cycle analysis
Cells of wt HEK293T, two ZFX knockout (KO) clones,
two ZNF711 KO clones, and three ZFX and ZNF711 dou-
ble knockout (DKO) clones were treated with 70% ethanol
for 2 h on ice, washed twice with cold PBS, and then la-
beled with DAPI (Thermo Fisher #62248) at a final con-
centration of 10 ug/ml for 30 min on ice, protected from
light. The flow cytometry assay was performed using BD
LSR II (USC Flow Cytometry Facility). Fixed cells were
gated on single cells via Width and Area signals. Cell cycle
analysis of the percentage of G0/G1, S and G2/M phases
were calculated from the DAPI-area histogram using Im-
ageJ (https://imagej.nih.gov/ij/).
RNA-seq
Total RNA was extracted using DirectZol RNA MiniPrep
kit (Zymo #R2052) following the manufacturer’s proto-
col. RNA integrity was checked using RNA 6000 Nano
kit (Agilent Technologies #50671511) on a 2100 Bioan-
alyzer (Agilent Technologies #G2939AA). RNA-seq li-
braries for controls, ZFX and ZNF711 KO clones, and
the DKO clones were made using the KAPA Stranded
mRNA kit with beads (Roche #KK8421) following the
manufacturer’s protocol. Samples were sequenced on
an Illumina HiSeq3000 with 50 bp single-ended reads.
The RNA-seq libraries of DKO cells transfected with
a control plasmid, wt ZFX FLAG, or ZFX ZF11-13
FLAG were prepared by Novogene. Paired-end sequenc-
ing was performed by the company. RNA-seq results were
aligned to GENCODE v19 and reads were counted us-
ing STAR (https://github.com/alexdobin/STAR). Differen-
tially expressed genes with absolute fold change >1.5
were determined using edgeR (https://bioconductor.org/
packages/release/bioc/html/edgeR.html). DAVID (https://
david.ncifcrf.gov/summary.jsp) was used for gene ontology
analyses; specifically, the Functional Annotation Cluster-
ing tool and the INTERPRO protein domain category was
used, with default settings (three genes required per cate-
gory) and medium stringency.
Construction of ZFX zinc finger deletion mutants
ZFX mutant expression constructs were generated by am-
plifying the ZFX-Myc-DDK expression vector (Origene
#RC214045) using primers with 15 bp complementary
overhangs flanking different ZFs to create constructs con-
taining ZF1-8, ZF9-13, ZF9-11, ZF11-13 or no ZF (see
Supplementary Table S2). The resulting constructs were
transformed into CopyCutter™ EPI400™ Chemically Com-
petent E. coli (Lucigen #C400CH10) and induced to high
copy number according to the manufacturer’s protocol.
Plasmids were purified using Qiagen miniprep kit (Qia-
gen #D4068) and the deletions were validated via Sanger
sequencing. Primers used for cloning and sequencing are
listed in Supplementary Table S2.
Transient transfection assays
To test transcriptional activity of the ZFXdeletionmutants,
HEK293T cells were seeded into six-well plates and trans-
fected during log phase growth. Transfection was carried
out with Lipofectamine 3000 (ThermoFisher #L3000015)
according to manufacturer’s instructions. After 24 h, cells
were lysed in TRI Reagent (Zymo #R2050-1-200) and
RNA was recovered by precipitation. Total RNA was con-
verted to cDNA using iScript (Bio-Rad #1708841BUN).
RT-qPCR was carried out using SYBR on a BioRad CFX
1000. Data points represent results from triplicate wells and
duplicate RT-qPCR readings. Primers used to monitor ex-
pression of endogenous genes are provided in Supplemen-
tary Table S2.
Chromatin Immunoprecipitation Sequencing (ChIP-seq)
ZFX (Cell Signaling Technology # 5419S), ZNF711
(24) and ZFY (Sigma #SAB2102775-100UL) antibodies
were used for ChIP assays in HEK293T and 22Rv1 cells,
as previously described (7). 400–900 ug chromatin was used
for ZFX (30 ul antibody), ZNF711 (5 ug antibody), and
ZFY (10 ul antibody) ChIP assays. For ZFX and ZNF711
antibody validation, western blots were performed in wild-
type and knockout cells. For ZFY antibody validation, we
demonstrated that ZFY can be ChIPed in male 22Rv1 cells
but not in female HEK293T cells, thus demonstrating that
there is no cross reactivity with the other two family mem-
bers (Supplementary Figure S1C). All ChIP-seq samples
for endogenous TFs were performed in duplicate, follow-
ing ENCODE standards. ChIP-seq libraries were prepared
using the KAPA HyperPrep kit (Roche #KK8503) follow-
ing the manufacturer’s protocol. Samples were sequenced
on an Illumina HiSeq3000 machine using 100 bp paired-
end reads for ZFX and 50 bp single-end reads for all other
samples. All ChIP-seq data were processed according to the
ENCODE3 ChIP-seq pipeline (https://www.encodeproject.
org/chip-seq/), and mapped to hg19; all data passed EN-
CODE quality standards. ChIP-seq peaks were called us-
ing MACS2 (https://github.com/taoliu/MACS), followed
by identifying common peaks between duplicates using
IDR (https://github.com/nboley/idr). To test DNA bind-
ing activity of mutant ZFX proteins, HEK293T cells were
transfected with a plasmid expressing a FLAG-tagged wt
ZFX or a mutated ZFX construct using Lipofectamine
3000 (Thermo Fisher #L3000015) according to the manu-
facturer’s protocol. Cells were harvested 24 h after trans-
fection for ChIP assays. For each ChIP assay, 5 ug of
FLAGantibody (Sigma-Aldrich #F1804-200UG) was used
with 150 ug chromatin. Also, 40 ug of chromatin, along
with an antibody toH3K36me3 (Cell Signaling Technology
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Figure 2. Loss of ZFX and ZNF711 in HEK293T cells inhibits cell proliferation. (A) Expression levels of ZFX/ZFY/ZNF711 in wt HEK293T cells. (B)
Locations of gRNAs used to create CRISPR/Cas9-mediated ZFX and/or ZNF711 knockouts. The deletion of ZFX in ZFX KO clone1 and clone2 and
the DKO clones were generated using ZFX gRNA1 and gRNA2. The deletion of ZNF711 in ZNF711 KO clone1 and the DKO clones was generated
using ZNF711 gRNA1 and gRNA2; the deletion of ZNF711 KO clone2 was generated using ZNF711 gRNA2 and gRNA3. (C) Western blots showing
the protein levels of ZFX and ZNF711 in wt HEK293T, ZFX KO clones, ZNF711 KO clones, and DKO clones; also shown is the level of p62 as a loading
control. (D) Proliferation assays using wt HEK293T, two different ZFX and two different ZNF711 KO clones, and two DKO clones; data points are the
mean of three biological replicates.
#9763S), was used for ChIP-seq analysis of wt HEK293T
and three DKO clones; the antibody was validated by the
company to demonstrate no cross-reactivity to unmodified,
mono- or di-methylated H3K36. ChIP-seq was performed
and analyzed as described above.
ChIP-exo
Approximately 100millionHEK293T cells were crosslinked
for each ChIP-exo assay using the ChIP-seq protocol de-
scribed above. Crosslinked cells, ZFXantibody (Cell Signal-
ing Technology # 5419S), and ZNF711 antibody (Thermo
Fisher #PA5-31815) were sent to Peconic, where the ChIP-
exo assay was performed (http://www.peconicgenomics.
com/services.html). Samples were sequenced on an Illu-
mina NextSeq 500 machine using 2 × 40 bp paired-end
sequencing generating ∼40 million reads per sample. Se-
quence reads were aligned to human (hg19) genome using
using bwa-mem (v0.7.9a) (http://bio-bwa.sourceforge.net/).
Peaks in ChIP-exo data were called using ChExMix (http:
//mahonylab.org/software/chexmix/).
DNA methylation EPIC arrays
500 ng genomic DNA was extracted from wt HEK293T
cells and the threeDKOclones using the ZymoQuick-DNA
Miniprep kit (Zymo #D3024) and bisulfite-converted us-
ing the Zymo EZ DNA Methylation kit (Zymo #D5001)
according to the manufacturer’s protocol. The bisulfite-
converted DNA was analyzed using Illumina EPIC
BeadArrays, as described (46). The BeadArrays were
scanned and the raw signal intensities were extracted from
the *.IDAT files using the ‘noob’ function in the minfi R
package. The beta value (a measure of change in DNA
methylation) was calculated as (M/(M+U)), in which M
andU refer to the (pre-processed) meanmethylated and un-
methylated probe signal intensities, respectively. Measure-
ments in which the fluorescent intensity was not statistically
significantly above background signal (detection P value >
0.05) were removed from the dataset. Probes located from
–1500 bp relative to the TSS and extending through the first
coding exon (using the IlluminaMethylationEPICManifest
RefGene annotation) were included in the analysis as a de-
fined set of ‘promoter’ probes for downstream analysis. The
cut off used for identifying hypomethylated or hypermethy-
lated probes was 0.2 for the absolute beta value difference
between the methylation level of a probe in the DKO cells
versus the wt HEK293T cells.
RESULTS
Loss of ZFX and ZNF711 inhibits cell proliferation and
causes large changes in the transcriptome of HEK293T cells
For our initial investigations into the function of the ZFX
family, we used the CRISPR/Cas9 system to functionally
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inactivate the ZFX and ZNF711 genes in female HEK293T
cells. We chose to use these cells because they express sim-
ilar levels of ZFX and ZNF711 (Figure 2A) but lack ZFY
(which is encoded on the Y chromosome). Because ZFX
and ZFY are so similar (96% overall), it is likely they have
a similar function and the use of female cells meant that we
only had to delete two TFs and not three to study the conse-
quences of loss of the entire family. Paired sets of plasmids
encoding guide RNAs designed to delete specific coding re-
gions of ZFX or ZNF711 (Figure 2A) and co-expressing
Cas9 were transfected into HEK293T cells; after 48 h in-
dividual cells were isolated using flow cytometry and then
grown into colonies. Genomic DNA was extracted and an-
alyzed using specific primers that spanned the deletion re-
gion (see Supplementary Table S2 for the sequence of all
guide RNAs and primers used in this study). We identi-
fied multiple colonies that showed no expression of ZFX
or ZNF711 (Figure 2C). However, our initial transfections
did not produce any cells lacking both ZFX and ZNF711,
despite screening a large number of colonies. Therefore,
we next transfected guide RNAs that target ZFX into the
ZNF711 knockout (KO) clone1 and selected single cell-
derived colonies, this time using conditioned media (70%
regular growth media plus 30% filtered used growth me-
dia) to provide a more supportive growth environment. We
obtained several double knockout (DKO) cell clones that
lacked expression of both ZFX and ZNF711 (Figure 2C).
The difficulty in obtaining DKO clones suggested that re-
duction of both ZFX and ZNF711 may have negatively
affected cell proliferation. To test this hypothesis, we per-
formed proliferation assays over a 168-hr time course. As
shown in Figure 2D, loss of either ZFX or ZNF711 reduced
the proliferation rate of HEK293T cells to approximately
the same level, whereas loss of both ZFX and ZNF711
caused a severe inhibition of cell proliferation; in general,
we have observed that DKO cells grow slowly and must be
kept at a high density to maintain viable cell populations.
The severe effects on proliferation in the ZFX and
ZNF711 KO and DKO cells suggested that loss of these
TFs was likely to cause major changes in the transcrip-
tome of HEK293T cells. To test this hypothesis, we per-
formed RNA-seq analysis of two ZFX KO clones, two
ZNF711 KO clones, three DKO clones lacking both ZFX
and ZNF711, and controls; each clone was analyzed using
3 biological replicates (producing 24 RNA-seq datasets in
total). Volcano plots showing the differentially expressed
genes (DEGs) in both of the ZFX KO clones, both of the
ZNF711 KO clones, and the three DKO clones are shown
in Figure 3A; see Supplementary Table S3 for the gene ex-
pression changes in all single and double knockout clones.
In general, we observed that cells lacking ZNF711 but re-
taining ZFX had fewer changes in the transcriptome than
did cells lacking ZFX but retaining ZNF711; cells lacking
both TFs showed the greatest number of upregulated and
downregulated genes. To address any potential issues due
to clonal variation, we compared the genes showing altered
regulation in each of the 3 individually derived clonal popu-
lations that lacked bothZFXandZNF711, identifying 2428
genes downregulated in at least two of the 3 DKO clones
and 1166 genes commonly downregulated in all three DKO
clones (Figure 3B). We also identified 3784 genes upregu-
lated in at least two of the three DKO clones and 2124 genes
commonly upregulated in all three of theDKO clones. Gene
ontology analyses of the commonly deregulated genes in
all three DKO clones revealed that different categories of
genes were upregulated versus downregulated (Figure 3C).
For example, genes that are upregulated upon loss of ZFX
andZNF711 include histone genes, zinc finger TFs and cad-
herins whereas genes that are downregulated upon loss of
the two TFs include kinases, ATPase, peptidases, chaper-
one proteins, and oxidoreductases. A complete list of the
clusters and all genes identified in each cluster can be found
in Supplementary Table S3J and K. In support of our find-
ing that loss of ZFX and ZNF711 resulted in proliferation
defects, the term ‘Cyclins and Cell Cycle Regulation’ was
one of the top identified pathways in the set of downreg-
ulated genes; additionally, flow cytometry cell cycle analy-
sis revealed that the DKO cells have a higher percentage of
G0/G1 cells and a lower percentage of G2/M cells than wt
HEK293T cells (see Supplementary Figure S2).
ZFX family members have essentially identical binding pat-
terns at CpG island promoters
Our next step in characterizing ZFX and ZNF711 was to
define their genome-wide binding profiles by performing
ChIP-seq in HEK293T cells using antibodies to ZFX and
ZNF711; we note that the antibodies we used for these
experiments have passed ENCODE validation criteria, as
all signal on a Western blot is eliminated in the individ-
ual knockout clones (Figure 2C). All ChIP-seq experiments
were performed using biological duplicates (see Supplemen-
tary Table S1); browser tracks from a single replicate of
ZFX and ZNF711 ChIP-seq are shown in Figure 4A. We
found that the binding profiles are very similar for ZFX
and ZNF711. As noted in Figure 1, ZFY is also highly re-
lated to ZFX and, based on the binding profiles of ZFX
and ZNF711, one might expect that ZFY would also have
a similar binding pattern as ZFX. However, ZFY is not ex-
pressed in female HEK293T cells. To allow a comparison of
the binding patterns of ZFX, ZFY, and ZNF711, we next
performed replicate ChIP-seq experiments in male 22Rv1
prostate cells for all three family members (ZFY antibody
validation was performed by demonstrating that no signal
was detected by ChIP using female HEK293T cells). We
found that all three family members showed highly corre-
lated binding patterns throughout the human genome (Fig-
ure 4A, B). Peaks were identified for all ChIP-seq datasets
and annotated into promoter vs. non-promoter binding
sites. We found that each factor binds mainly to promoters
that are CpG islands (Figure 4C). The CpG island promot-
ers bound by the three factors are essentially the same, with
a total of 10 723 CpG island promoters bound by the union
of ZFX, ZFY and ZNF711(Figure 4D), corresponding to
72% of the active CpG island promoters in 22Rv1 cells.
ZFX andZNF711 have properties of a transcription activator
when bound downstream of the TSS
The binding patterns shown above demonstrate that ZFX
family members bind to CpG island promoters. To further
investigate the binding pattern of these TFs, we performed
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Figure 3. Reduction in ZFX and ZNF711 levels causes large effects on the transcriptome. (A) Volcano plots showing the differentially expressed genes
(DEGs) identified via RNA-seq in comparisons of wt HEK293T versus ZFX KO clone1, KO clone2, ZNF711 KO clone1, KO clone2, DKO clone1, DKO
clone2, or DKO clone3. (B) Comparison of DEGs commonly downregulated or upregulated in all three DKO clones. (C) Gene ontology analysis of the
1166 commonly downregulated and 2124 commonly upregulated genes in all three DKO clones.
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Figure 4. ZFX family members have essentially identical binding patterns at CpG island promoters. (A) Browser tracks showing ZFX family member
binding profiles in female HEK293T kidney cells and male 22Rv1 prostate cells. Also shown is a zoom in on a single peak located in the DOCK7 promoter
region. (B) Shown is a heatmap illustrating the genome-wide correlation of ZFX family member binding patterns in 22Rv1 cells. (C) Bar graph of genomic
distributions of ZFX familymember binding sites in 22Rv1 cells in promoter and non-promoter regions (left) and bar graph showing the relative distribution
of binding sites in CpG island (CGI) promoters and non-CpG island promoters (right). (D) Venn diagram comparing the sets of CpG island promoters
bound by ZFX, ZFY and ZNF711 in 22Rv1 cells.
aK-means clustering based on the peak locations relative to
the nearest TSS, identifying four groups of binding sites for
ZFX and ZNF711 (Figure 5A). Interestingly, the strongest
binding sites comprise ∼1200 peaks (cluster 1) which are
located downstream of the TSS. An additional larger set
of ∼4700 peaks (cluster 3) has a similar downstream loca-
tion, but a slightly weaker binding profile. We also identi-
fied ∼1400 peaks (cluster 2) that are located upstream of
the TSS and a set of weaker peaks (cluster 4) that appear
to have a Y-shaped pattern. Further analysis of the peaks
in cluster 4 revealed peaks that are upstream (cluster 4.1),
downstream (cluster 4.2), and over the TSS (cluster 4.3), as
well as a set of peaks that are very small and have no distinct
binding pattern (cluster 4.4).We note that the upstream and
downstream peaks in cluster 4 have a different location than
the peaks in clusters 1, 2 and 3. The peaks in clusters 1 and
3 are located downstream, but quite near, the TSS whereas
the peaks in cluster 4.2 are much farther downstream (close
to +2 kb). Similarly, the peaks in cluster 2 are located up-
stream, but near, the TSS whereas the peaks in cluster 4.1
are much farther upstream (close to –2 kb).
The fact that most of the strongest ZFX and ZNF711
peaks are downstream of the TSS (clusters 1 and 3) raises
several questions. For example, do these TFs regulate tran-
scription from a location downstream of the TSS or is regu-
lation achieved only when the TFs are bound to the minor-
ity of sites upstream of the TSS? Also, do the TFs function
as direct activators or repressors and, if so, does their ac-
tivity differ depending on the binding location? To answer
these questions, we compared the binding profiles of ZFX
and ZNF711 at all bound promoters and at promoters that
we identified as commonly downregulated or upregulated
in all 3 DKO clones (Figure 5B). The tag density plots of
all ZFX or ZNF711 peaks were quite broad and showed a
large peak at +240 and a shoulder at –240. Interestingly, the
promoters that are downregulated upon loss of ZFX and
ZNF711 have very strong peaks downstream of the TSS
with a frequency peak at +240, suggesting that ZFX and
ZNF711 function as activators when bound downstream of
the TSS on that group of promoters. In contrast, promot-
ers that are upregulated upon loss of ZFX and ZNF711
have very flat binding profiles, suggesting that genes that
show increased expression in the DKO cells are indirectly
regulated by ZFX and ZNF711, perhaps because they are
components of affected signaling pathways. The pie charts
show the percentage of deregulated genes that have promot-
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Figure 5. ZFX and ZNF711 have properties of a transcription activator when bound downstream of the TSS. (A) ZFX and ZNF711 peak sets from
HEK293T cells were clustered using K-means clustering, identifying four sets of peaks with distinct binding sites (left); cluster 4 (combination peaks)
was subsequently re-clustered, identifying 4 subsets (right). Tag density plots for each of the 4 different clusters are presented on top of the heatmaps.
(B) Average signals of ZFX and ZNF711 ChIP-seq reads in wt HEK293T at all promoters bound by each TF (top), promoters of genes with decreased
expression in all three DKO clones (middle), and promoters of genes with increased expressions in all three DKO clones (bottom). Also shown, for both
the downregulated and the upregulated gene categories, is the percentage of genes whose promoters are bound by ZFX or ZNF711 in peak categories 1–4,
or not bound by ZFX or ZNF711.
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ers bound by ZFX or ZNF711, broken into the different
clusters; in total, 86%of the downregulated genes are bound
by ZFX or ZNF711 whereas only 24% of the upregulated
genes are bound by ZFX or ZNF711 (and most of these
have peaks located in the weaker cluster 4). Therefore, ZFX
and ZNF711 appear to function mainly as transcriptional
activators, but only when they are bound downstream of the
TSS.
ZFX family members bind throughout the first several hun-
dred base pairs of the transcribed region of their target genes
Because the majority of the ZFX binding sites occur down-
stream of the TSS within the transcribed region, we anno-
tated the position of the downstream ZFX binding sites rel-
ative to gene structure (Figure 6A). We found that most
of these binding sites fall within the 5′ UTR, the first cod-
ing exon, or the first intron, suggesting that there was not
a preference for binding to coding or non-coding regions
downstream of the TSS. This was true for the set of all
ZFX peaks and for the set of ZFX peaks found at the genes
that are commonly downregulated in all three of the DKO
clones. However, although we used the genomic location of
the summit of the called ChIP-seq peaks for the location
analysis, the ‘genomic summit’ of a ChIP-seq peak does not
necessarily correspond to the location of the precise bind-
ing site (e.g. due to the random nature of the sonication of
the chromatin). The precise identification of a peak sum-
mit may also be compounded when analyzing ZFX and
ZNF711. We note that the tag density plots shown in Fig-
ure 5 show a fairly broad binding profile for ZFX family
members. Also, close inspection of single peaks reveals a
relatively wide peak at individual promoters (see Figure 4A
for the single ChIP-seq peak in the DOCK7 promoter). For
comparison to another multi-finger ZNF, we calculated the
average peak width of ZFX (13 ZFs) and CTCF (11 ZFs)
peaks and found that the ZFX peaks (average width of 1816
bp) are quite a bit wider than the CTCF peaks (average
width of 747 bp); the ChIP-seq experiments for both TFs
were performed in our lab using the same protocol. The
broadZFXandZNF711 peakwidths suggested a need for a
more precise delineation of the binding sites. Therefore, we
used ChIP-exo, a modification of ChIP-seq that improves
the resolution of binding sites (25). The use of ChIP-exo re-
duced the average width of the ZNF711 binding sites from
∼1800 to ∼300 bp, providing a more distinct pattern of up-
stream and downstream binding (Figure 6B). We compared
the genomic locations of the wide ZNF711 ChIP-seq bind-
ing sites to the narrow ChIP-exo peaks (in both cases, using
the peak summits obtained using the ENCODE pipeline).
We also used peak information from ChExMix, a program
designed specifically to identify precise binding sites from
ChIP-exo data (Figure 6C). In all cases, the downstream
ZNF711 binding sites are spread throughout the 5′UTR,
first coding exon, and first intron. These results suggest that
the localization of ZNF711 is not related to the classifica-
tion of the transcribed region to which it binds.
Previous studies have identified a ZNF711 motif (AG-
GCCTAG) using ChIP-seq data from a brain tumor cell
line SH-SY5Y (24). However, these studies used the entire
ChIP-seq peak width (which, as shown above, covers a very
large area of the proximal promoter region), making it dif-
ficult to be sure if the identified motif was involved in direct
recruitment of ZNF711 or if it was instead a motif com-
monly found in CpG island promoters. Also, the ChExMix
program, which is used to call motifs in ChIP-exo data,
identified a smaller motif of GGCCT. This shorter motif
is similar to a short motif GGCC identified for mouse Zfx
using ChIP-seq data (26) and for ZFY using in vitro assays
(27–29). To more precisely define the ZNF711 binding mo-
tif, we performedmotif analysis using the top 5000 ZNF711
peaks identified by ChIP-seq (using the entire width of the
MACS2 peaks), identified by ChIP-exo (using the entire
width of the MACS2 peaks) or identified by the ChExMix
program (in this case, because ChExMix outputs a single nt
for each peak, the sequence was extended +/- 10bp for mo-
tif analysis). We found that essentially all of the top 5000
ZNF711 ChIP-seq peaks contain the known ZNF711 mo-
tif and the ChIP-exo GGCCT motif (Figure 6D). How-
ever, because the ZNF711 peaks are quite wide (∼2 kb),
they span a large proportion of the promoter region. As
shown in Figure 4, ZNF711 binds mainly to GC-rich CpG
island promoters. This suggests that these motifs may have
been identified because they are GC-rich and commonly
found in CpG island promoters. In fact, when we analyzed
5000 2 kb randomized regions from CpG island promot-
ers, we found that all 2 kb randomized promoter regions
also contain these same motifs. As noted above, ChIP-exo
reduced the peak widths to an average size of 200–300 nt.
Motif analysis of the ChIP-exo peaks showed a reduction
in the number of peaks that contained the known ZNF711
motif or the shorter GGCCT motif, although the peaks
did have a higher percentage of both motifs than did ran-
domly selected 200 bp regions from CpG island promoter
downstream regions. Finally, analyzing the sequences +/-
10 nt from the ChExMix peak summits resulted in a fur-
ther drop in the percentage of peaks that contain the motifs.
In this case, ∼25% of the ChExMix peak locations contain
the known ZNF711 peak and ∼40% contain the smaller
GGCCT motif. However, of note, randomized 20b regions
contain these motifs at a very low frequency (∼5%). These
results suggest that the ZNF711 binding sites are enriched
in both the known motif and the GGCCT motif, but the
majority of sites do not contain either motif. We also note
that both the ZNF711 motif and the GGCCT motif are
present throughout the genome, albeit at a higher density
in CpG islands (data not shown). Thus, the presence of a
motif is perhaps supportive of binding but does not appear
to be absolutely required nor sufficient for binding.
Visual inspection of individual promoters revealed that
not only did the ChIP-exo method result in narrower peaks
overall, but the broad ChIP-seq peaks were fractured into
multiple peaks in the ChIP-exo datasets (Figure 6E). These
results suggest that there are multiple ZNF711 binding
events for each promoter. Due to limitations of the ChIP
assay, we cannot distinguish between multiple ZNF711
molecules bound to a given promoter in the same cell or
a single ZNF711 molecule binding at different locations
in a given promoter in different cells. Perhaps the multiple
copies of CCGGT elements within CpG island promoters
simply help to localize ZFX family members to the region
of open chromatin in a CpG island promoter, with the exact
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gkaa384/5837054 by C
alifornia Institute of Technology user on 21 M
ay 2020
10 Nucleic Acids Research, 2020
Figure 6. Characterization of ZFX and ZNF711 binding sites. (A) Classification of binding sites based on genomic locations of all ZFX peaks located
downstream of the TSS and ZFX downstream peaks at promoters of genes down-regulated in all 3 DKO clones. (B) Classification of ZNF711 downstream
ChIP-seq peaks, downstream peaks identified using read2 of the ChIP-exo dataset, and downstream peaks identified by the ChexMix program (+/-10 nt
from the nt identified as the binding site by the program). (C) Tag density plots of all ZNF711 peaks from standard ChIP-seq and fromChIP-exo. (D)Motif
analysis using the top 5000 peaks identified from standard ZNF711 ChIP-seq (average width 1800 nt), ChIP-exo read2 (average width 300 nt), ChIP-exo
by the ChexMix program (20 nt), and randomized CpG island promoter regions (width 2 kb, 200 bp, and 20 nt). The peaks were searched for the known
ZNF711 motif and the 5 nt motif identified by ChIP-exo. (E) Zoom-in comparison of peaks from ZNF711 standard ChIP-seq replicates and ChIP-exo
replicates.
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distance from the TSS not being important for regulation as
long as binding is downstream of the TSS. We note that we
performed similar ChIP-exo experiments using a ZFX an-
tibody. Unfortunately, although the overall patterns were
the same as for ZNF711, the ZFX antibody did not per-
form as well in ChIP-exo in either of two independent ex-
periments (producingmuch smaller peaks overall, but in the
same locations) and therefore this data was not included in
our analyses.
As noted above, the ZFX family binds almost exclusively
to CpG island promoters. Although the identified DNA
binding motifs do not contain a methylatable CpG dinu-
cleotide, there are many CpGs within each promoter region
bound these TFs. Changes in the levels ofDNAmethylation
can have major effects on promoter activity, with increased
methylation leading to gene silencing (30,31). To address
the question as to whether binding of ZFX and ZNF711
affects the DNA methylation level at target promoters, we
performed DNA methylation assays using Illumina EPIC
arrays for wt HEK293T cells and the three DKO cell lines.
As shown in Supplementary Figure S3, we found that the
loss of ZFX and ZNF711 results in a slight hypomethy-
lation at many promoters, but that this overall promoter
hypomethylation could not be specifically associated with
ZFX- or ZNF711-mediated gene regulation.
The first 10 C2H2 zinc fingers of ZFX are dispensable for
DNA binding and transcriptional activity
As our next step, we wished to define which of the C2H2
ZFs were involved in recruitment of the ZFX family to
chromatin. As noted above, ZFX and ZFY have 13 C2H2
ZFs but ZNF711 has amino acid changes that eliminate the
C2H2 structure for ZF3 and ZF7 (Supplementary Figure
S1), suggesting that perhaps ZFs closer to the C-terminus
are used for DNA binding. To test this hypothesis, we cre-
ated ZFX protein constructs that contained the N-terminus
and only ZF1-8 or the N-terminus and only ZF9-13 (Fig-
ure 7A; Supplementary Figure S4A). Plasmids expressing
FLAG-tagged versions of wt and mutant ZFX proteins
were transfected into HEK293T and/or DKO cells, in vivo
expression was confirmed by Western blot (Supplementary
Figure S4B), and ChIP-seq was performed using a FLAG
antibody. The FLAG-tagged wt ZFX produced a genomic
binding pattern similar to the pattern obtained using the
endogenous ZFX antibody, as did the FLAG-tagged ZFX
that lacked ZF1-8 but contained ZF9-13 (Figure 7B). In
contrast, FLAG-tagged ZFX containing ZF1-8 but lack-
ing ZF9-13 did not bind to the genome, even though it was
expressed at the same level as the FLAG-tagged wt ZFX.
These results suggested that ZF9-13 are involved in binding.
Many C2H2 ZNFs, such as the Sp1 andKruppel-like family
(KLF) members, use three ZFs to bind to DNA (4,32,33).
Therefore, we next created additional mutant ZFXproteins,
one containing only ZF9-11, one containing only ZF11-
13, and one construct which lacked all ZF (no ZF). ChIP
analysis revealed that ZF11-13 are sufficient for recruit-
ment of ZFX to promoter regions (Supplementary Figure
S4C). For comparison, we performed a prediction of the
DNA binding motifs for the different ZFX mutant con-
structs using the website tool ‘DNA-binding Specificities
ofCys2His2 ZincFinger Proteins’ (http://zf.princeton.edu/);
the predicted motif for ZFX ZF11-13 closely matches the
motif identified using the ChIP-exo peaks (Supplementary
Figure S5).
C2H2 ZFs have also been implicated in protein-protein
interactions (34), suggesting that perhaps some of the ZFs
not involved in genomic recruitment may be involved in
transcriptional activity. To examine this possibility, we
tested the ZFX constructs using a transient transfection re-
porter assay. ZFX expression constructs were transfected
into DKO cells and the expression of endogenous genes was
monitored byRT-qPCR after 24 h, using triplicate transfec-
tions for each data point. We examined expression of two
genes (LONRF2 and CAPN2) whose promoters are bound
by both ZFX and ZNF711 in wt HEK293T cells and which
show a reduction in gene expression in all 3 DKO clones, of
one gene (FOS) that is upregulated in theDKOcells (a puta-
tive indirect target gene), and of one gene (HOXC4) which
shows no expression changes in the DKO cells. As shown
in Figure 7C, we observed strong upregulation by a subset
of the transfected ZFX constructs only for the two genes
which are bound by ZFX in wt HEK293T cells and that
show a reduction in RNA levels upon loss of ZFX family
members (the putative direct target genes). This increased
expression was observed in multiple, independent experi-
ments using two independently derived DKO clones. The
putative indirect target gene and the control gene were not
affected upon transfection of the ZFX constructs. We ob-
served that the ability of the ZFX constructs to bind to the
genome was correlated with the ability to increase expres-
sion levels of the target genes. Because the FLAG-tagged
ZFXZF11-13 could increase expression of endogenous tar-
get genes as well as the FLAG-tagged wt ZFX construct,
this suggests that the first 10 C2H2 ZFs are dispensable
for genomic DNA binding and transcriptional activity (27).
To further examine this possibility, we transfected FLAG-
tagged wt ZFX, FLAG-tagged ZFX ZF11-13, or a control
plasmid not expressing ZFX into DKO cells and compared
global expression by RNA-seq (Figure 8). Volcano plots
DEGs inDKOcells transfectedwithwt ZFXorZFXZF11-
13, as compared to the control cells, are shown in Figure
8A; see Supplementary Table S3 for all DEGs.We identified
thousands of genes that responded to the reintroduction of
ZFX into the DKO cells. To further compare the cellular
response to a 24 h exposure to wt ZFX versus ZFX ZF11-
13, we created a volcano plot comparing these two datasets.
We found that there are very few genes that show differ-
ential responses to the wt ZFX (containing 13 ZFs) versus
the ZFX ZF11-13 (containing only the final three ZFs). To
identify the putative direct target genes in DKO cells that
are responsive to the reintroduction of ZFX, we compared
the 846 genes that are bound by ZFX and ZNF711 in wt
HEK293T cells and show a decrease in mRNA levels in all
three DKO clones and the 2275 genes that show increased
levels in DKO cells transfected with either FLAG-tagged wt
ZFX or ZFX ZF11-13 (Figure 8B). We found 277 respond-
ing promoters. The binding patterns of transfected FLAG-
tagged wt ZFX and FLAG-tagged ZFX ZF9-13 at the re-
sponding promoters (identified in Figure 8B) recapitulate
the endogenous ZFX binding pattern, which has a peak at
+240 downstream of the TSS (Figure 8C). We found that
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Figure 7. Functional analysis of the ZFX protein. (A) Schematic of FLAG-tagged ZFX zinc finger (ZF) mutant constructs. (B) Browser tracks showing
genomic binding profiles of endogenous ZFX and FLAG-tagged wt ZFX and ZFX mutants in HEK293T cells. (C) Tag density plots of ChIP-seq peaks
comparing endogenous ZFX and ZFX ZF9-13 peak locations in HEK293T cells. (D) Heatmaps showing ChIP-seq data from FLAG-tagged wt ZFX and
ZFX ZF9-13 centered on the genomic locations of the endogenous ZFX peaks. (E) Expression levels following transfection with different ZFX constructs
(as analyzed by RT-qPCR) of two genes (LONRF2 and CAPN2) whose promoters are bound by both ZFX and ZNF711 in wt HEK293T cells and which
show a reduction in gene expression in all three DKO clones, of one gene (FOS) that is upregulated in all three DKO cells (a putative indirect target gene),
and of one gene (HOXC4) that shows no expression changes in the DKO cells. Expression data were normalized to the control (cells transfected with an
unrelated plasmid). Three independent experiments were performed using two different clonal populations of DKO cells; data points represent results from
triplicate wells and duplicate PCR readings. Error bars indicate the pooled standard deviations of the means for the constructs and for the normalizing
control.
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Figure 8. ZFXZF11-13 has very similar transcriptional activities as wt ZFX. (A) Volcano plots showing the differentially expressed genes (DEGs) identified
via RNA-seq in comparisons of DKO cells 24 hr after transfection with FLAG-tagged wt ZFX vs. a control plasmid, FLAG-tagged ZFX ZF11-13 vs.
a control plasmid, and FLAG-tagged wt ZFX vs. FLAG-tagged ZFX ZF11-13. (B) Shown is a Venn diagram comparing the 846 genes that are bound
by ZFX and ZNF711 in wt HEK293T cells and show a decrease in mRNA levels in all three DKO clones and the 2275 genes that show increased levels
in DKO cells transfected with either FLAG-tagged wt ZFX or ZFX ZF11-13. (C) Shown is a tag density plot of ChIP-seq data for endogenous ZFX,
FLAG-tagged wt ZFX, ZFX ZF9-13, or ZFX ZF1-8 at the set of 277 responding promoters identified in panel B. (D) Motif coverage analysis of the 277
responding promoters.
274 of the 277 responding promoters have the known motif
(Figure 8D).
DISCUSSION
ZFX has been shown to have increased expression in tu-
mors, with high expression negatively correlating with pa-
tient survival (14–23,35). The other 2 members of the ZFX
family, ZFY and ZNF711, have not been as well-studied,
especially in the cancer field. However, mutations in the
ZNF711 coding sequence have been found to be associated
with several families that display X-linked inherited mental
retardation (24,36–38), suggesting that ZFX family mem-
bers may be critical mediators of cell proliferation and/or
have a role in tissue-specific differentiation. However, the
previous studies of the ZFX family members have mainly
been correlative analyses, providing essentially no insights
into the mechanisms by which these TFs may function. We
have used CRISPR-mediated deletion to demonstrate that
loss of ZFX and ZNF711 (in cells naturally lacking ZFY)
has severe defects in proliferation. Using a combination of
ChIP-seq and RNA-seq, we have demonstrated that this 3-
member family of C2H2 ZNFs activates transcription when
bound downstream of the TSS in CpG island promoters.
Because the ZFX family members bind to thousands of
CpG island promoters, many of which regulate genes re-
quired for essential ‘housekeeping’ functions, it is possible
that the these TFs act in a similar as manner as the MYC
family of oncogenic transcription factors (39). Although
MYC binds to thousands of promoters, it has been shown
to havemodest effects on the activity of any given promoter.
Cells lacking MYC are impaired in proliferation; they can
enter the cell cycle but soon cease to divide (40). Similarly,
we show that cells lacking the ZFX family members have
profound proliferation defects, butmodest effects on the cell
cycle parameters. We have shown that ZF11-13 are neces-
sary and sufficient for DNA binding, and, in combination
with the N terminal region, constitute a functional trans-
activator. We note that a previous study used an in vitro
DNA binding assay to show that ZF12-13 of mouse Zfy2
can bind to a specific oligonucleotide containing an AG-
GCCY motif (27). However, it was not known if those ZFs
of the ZFX family members would be capable of recruit-
ment to, or stable interaction with, CpG island promoter
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regions. We have now shown that the last three ZFs of hu-
man ZFX have the capability of stable in vivo binding at
target promoters in the context of a chromatin environment.
Interestingly, ChIP-exo experiments suggest that the identi-
fied DNA binding motif may aid in recruiting ZFX family
members to the genome but the presence of a motif under
the direct binding site is neither sufficient nor, in some cases,
necessary for genomic recruitment.
Although this study has extended our knowledge about
this uncharacterized family of ZNF transcription factors,
several crucial questions remain unanswered. (i) What dis-
tinguishes a responsive from a non-responsive target gene?
For example, ∼10 000 CpG island promoters are bound by
ZFX familymembers in a given cell type.However, less than
half of the bound promoters show responsiveness to loss of
ZFX and ZNF711 in the knockout HEK293T cells (Fig-
ure 3) or after knockdown of all three family members in
22Rv1 prostate cancer cells (data not shown). To date, we
have not been able to identify differences in promoter struc-
ture, activity level, or epigenetic modifications that distin-
guish promoters that are bound by ZFX and ZNF711 and
show decreased expression in the DKO cells from those that
are bound and do not show decreased expression (data not
shown). (ii) Is there functional significance that ∼75–80%
of the binding sites in the promoters that are downregulated
in the DKO cells are within the transcribed region? Certain
ZNFs have been shown to be both RNA and DNA binding
proteins (34,41–45). At first thought, this binding site dis-
tribution might suggest a role for ZFX in RNA processing.
However, the binding sites are distributed throughout the 5′
UTR, the first coding exon, or the first intron. This distribu-
tion pattern makes it difficult to envision a role for ZFX in
a post-transcriptional process such as splicing, unless ZFX
can play a different role at different promoters. Perhaps a
more reasonable possibility could be a role in RNA traf-
ficking through interaction of ZFX with a site within the 5′
region of the transcripts. As an initial investigation into the
possibility that ZFX regulates its target genes by binding to
a GGCCUmotif in the target RNAs, we performed eCLIP
in FLAG-tagged wt ZFX transfected HEK293T cells using
a FLAGantibody has been previously well-characterized to
work in the eCLIP assay. However, we did not detect ZFX
binding to the 5′ regions of RNAs encoded from the ZFX
target promoters (data not shown). Another possibility is
that, due to their binding to transcribed regions, ZFX and
ZNF711 may be involved in transcriptional elongation. To
test this possibility, we performed ChIP-seq for the elon-
gation mark H3K36me3 in wt HEK293T cells and in the
three DKO clones (Supplementary Figure S6). We found
that promoters bound by ZFX and ZNF711 have much
higher levels of H3K36me3 in wt HEK293T cells than do
promoters not bound by these TFs. Interestingly, we found
that the levels ofH3K36me3 are reduced in theDKO cells at
all promoters, not just at those bound byZFXandZNF711.
Also, in the DKO cells, reduction of H3K36me3 occurs at
genes that are downregulated and at genes that show no
changes in expression. Therefore, it seems that ZFX family
members may be important in recruiting an H3K36me3 hi-
stone methyltransferase to transcribed regions, but changes
in the levels of this mark are not correlated with changes
in gene expression. (iii) Are the ZFX C2H2 ZFs that are
not required for genomic recruitment involved in other pro-
cesses? ZFs have been implicated in protein-protein interac-
tions (33). ZF1, ZF2, ZF4-6 and ZF8-10 are well-conserved
between ZFX, ZFY and ZNF711 (Figure 1) and yet are not
required for genomic recruitment. It is possible that inter-
actions with co-regulators could be mediated through one
or more of these non-DNA binding ZFs. However, trans-
fection experiments suggest that ZFX ZF11-13 has very
similar transcriptional activity as does wt ZFX, suggesting
that co-activators may interact with the N-terminus of ZFX
(which is conserved in the ZFX ZF11-13 construct). Future
studies are required to completely understand how the ZFX
family plays an essential role in normal and disease cellular
physiology.
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